(Q33386511)

English

Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial

scientific article

Statements

Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial (English)
Jean-Christophe Eymard

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit